Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 21,343 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Mental Illness Clear all

Conditions: Stress Disorders, Post-Traumatic
Interventions: Cognitive behavioral therapy (CBT), Educational session and treatment as usual; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: New York, New York • Queens, New York

Conditions: ADHD, Attention Deficit Hyperactivity Disorder
Interventions: Atomoxetine and OROS Methylphenidate; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Opioid Use Disorder, OAT
Interventions: [11C]OMAR; Drug
Lead sponsor: Yale University; Other
Eligibility: 25 Years to 65 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Substance Abuse
Interventions: drug prevention curriculum; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 14 Years to 19 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Psychosis
Interventions: Family Focused Treatment, Enhanced Care; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 35 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 7
States / cities: Los Angeles, California • San Diego, California • New Haven, Connecticut + 4 more

Conditions: Cocaine Abuse, Cocaine-Related Disorders
Interventions: Modafinil, Levodopa/Carbidopa, Naltrexone HCl, Placebo, Motivational Interviewing (MI), Contingency management (CM), Cognitive-Behavioral Therapy (CBT); Drug · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 55 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: FOCAL+, VR-FOCAL+; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 16 Years to 19 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Primary Progressive Aphasia
Interventions: HD-tDCS, Sham; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 45 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Neuropathic Pain
Interventions: Smoked cannabis; Drug
Lead sponsor: Center for Medicinal Cannabis Research; Other
Eligibility: 21 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: San Diego, California

Conditions: Opioid Use Disorder, Alcohol Use Disorder
Interventions: Extended Release Naltrexone, Treatment As usual; Drug · Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Schizophrenia Disorders
Interventions: Placebo (single and multiple doses), AQW051 2 mg (single and multiple doses), AQW051 15mg (single and multiple doses), AQW051 100mg (single dose), and 50mg (multiple doses); Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Glendale, California • Willingboro, New Jersey

Conditions: Bipolar Disorder Depression
Interventions: Lurasidone (Latuda); Drug
Lead sponsor: Martin Lan; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Dementia With Lewy Bodies, REM Sleep Behavior Disorder, Parkinson's Disease Dementia
Interventions: Nelotanserin, Placebo; Drug
Lead sponsor: Axovant Sciences Ltd.; Industry
Eligibility: 50 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 23
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 20 more

Conditions: Mental Illness
Interventions: Express Access; Behavioral
Lead sponsor: Outcome Referrals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Framingham, Massachusetts

Conditions: Substance Use Disorders, Alcohol Use Disorder, Opioid Use Disorder
Interventions: Not listed
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 185,810 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Opioid-Related Disorders
Interventions: Cycloserine; Drug
Lead sponsor: Yale University; Other
Eligibility: Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 1998
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Alzheimer Disease, Dementia, Mild, Mild Cognitive Impairment
Interventions: Electroencephalogram (EEG) system, Standard Neuropsychological Testing, Additional neuropsychological tests; Device · Behavioral
Lead sponsor: Boston University; Other
Eligibility: 20 Years to 90 Years
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fragile X Syndrome, Autism Spectrum Disorder, Autistic Disorder, Asperger Syndrome
Interventions: Alpha Auditory Entrainment, Sham; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 10 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Sexual Risk Behavior, Childhood Sexual Abuse, Stress Disorders, Post-Traumatic
Interventions: Cognitive Processing Therapy for Sexual Risk, Supportive Psychotherapy, Sexual Risk Reduction Intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 3
States / cities: Coral Gables, Florida • Boston, Massachusetts

Conditions: Amnesia, Dementia, Healthy, Nervous System Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 830 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alcohol Use Disorder
Interventions: Cannabidiol; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 16 Years to 22 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Generalized Anxiety Disorder (GAD)
Interventions: EXOMIND (BTL-699-2) Active treatment, EXOMIND (BTL-699-2) Sham treatment; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 22 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Denver, Colorado • Chicago, Illinois • Newburgh, Indiana

Conditions: Autism Spectrum Disorder
Interventions: Tele-assessment + In-person assessment, Tele-assessment only; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 36 Months to 72 Months
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Anxiety, Depression - Major Depressive Disorder, Stress
Interventions: Mobile health application; Behavioral
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: College Station, Texas

Search by objective public record fields.

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

Medications for Stopping Cocaine Dependence and Preventing Relapse

Improving ADHD Teen Driving - Virtual Reality

HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms

Medicinal Cannabis for Painful HIV Neuropathy

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Behavioral Health Referrals Study

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Neurobiology of Opioid Dependence: 3 - 3

Event-Related Potential (ERP) Components in Clinical Diagnosis

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

HIV Prevention and Trauma Treatment for Men Who Have Sex With Men With Childhood Sexual Abuse Histories

Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders

Cannabidiol in Youth Alcohol Use Disorder

Device for Treating Generalized Anxiety

Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?

An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College Students